Perspective
Assessing the Case Against Direct-to-Consumer Drug Advertisements
November 14, 2025
Featured Experts: Neeraj Sood, PhD
Research
All Research Featured Research
Perspective
The Unfinished Work of the No Surprises Act: Cost Transparency for Planned Care
November 12, 2025
Featured Experts: Erin L. Duffy, PhD, MPH
Perspective
Stop Overloading Older Adults With Medicare Plan Choices
October 21, 2025
Featured Experts: Wändi Bruine de Bruin, MSc, PhD, Jonathan Blum
Perspective
HHS’s Chance to Save Hundreds of Boys
September 14, 2025
Featured Experts: Elizabeth Currid-Halkett, PhD
Perspective
Should the Government Control Drug Prices? Yes… Wise Regulation Will Reform an Out-of-Control Industry
September 2, 2025
Featured Experts: Paul Ginsburg, PhD, Steve M. Lieberman, MPhil, MA
Perspective
The Cost of Chronic Disease: An Economist’s Perspective on Making America Healthy Again
September 2, 2025
Featured Experts: Matthew Kahn, PhD
Perspective
When Patient Access to Results Complicates Care
August 19, 2025
Featured Experts: Manav Midha
Perspective
Hospital at Home Treatment is Working — Congress Must Now Give it a Future
August 15, 2025
Featured Experts: Manav Midha
Evidence Base
A Diabetes Paradox: Better Health, But Still Out of Work
June 24, 2025
Featured Experts: Jack M. Chapel, PhD
Perspective
Peer-to-Peer Prior Authorization: Is Physician Participation Ethical?
June 20, 2025
Featured Experts: Manav Midha
Perspective
What RFK Jr. Gets Wrong About Conflicts of Interest
June 12, 2025
Featured Experts: Genevieve P. Kanter, PhD
Perspective
Agency Overreach Leaves Patients Untreated
June 10, 2025
Featured Experts: Joseph Grogan, JD
Evidence Base
New Alzheimer’s Blood Tests Have the Potential to Supercharge Clinical Trials
May 27, 2025
Featured Experts: Phyllis Barkman Ferrell, DrPH, MBA, Desi Peneva, MS, Mireille Jacobson, PhD, Maria-Alice Manetas
Perspective
Ensuring Most-Favored Nation Drug Pricing Doesn’t Sicken Us
May 20, 2025
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Perspective
The Biotech Industry Needs to Make Its Case for Bold Change to the White House
May 7, 2025
Featured Experts: Joseph Grogan, JD
Perspective
The U.S. Drug Supply is Vulnerable. Why Tariffs Are the Wrong Prescription.
May 6, 2025
Featured Experts: Geoffrey Joyce, PhD
Evidence Base
Patients Win When NIH Swings for the Fences
May 1, 2025
Featured Experts: Dana Goldman, PhD, Bob Kocher, MD
Perspective
These Breakthrough Gene Therapies Cost Millions of Dollars. Is a Mortgage Model the Secret to Paying for Them?
May 1, 2025
Featured Experts: William Padula, PhD